IRIS
AIUTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.064
EU - Europa 1.950
AS - Asia 659
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
AF - Africa 3
OC - Oceania 2
Totale 13.688
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.054
DE - Germania 823
SG - Singapore 328
CN - Cina 221
UA - Ucraina 221
IT - Italia 203
GB - Regno Unito 180
IE - Irlanda 177
RU - Federazione Russa 127
SE - Svezia 79
FI - Finlandia 49
FR - Francia 45
KR - Corea 43
BE - Belgio 17
IN - India 11
VN - Vietnam 10
CA - Canada 8
HK - Hong Kong 8
JP - Giappone 7
KG - Kirghizistan 7
TR - Turchia 7
IR - Iran 6
ES - Italia 4
EU - Europa 4
AT - Austria 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
NL - Olanda 3
PL - Polonia 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
EG - Egitto 2
GR - Grecia 2
IL - Israele 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
BY - Bielorussia 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
ID - Indonesia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 13.688
Salva come PNG Salva come JPEG
Città #
Wilmington 2.637
Woodbridge 2.636
Houston 2.476
Fairfield 639
Ann Arbor 391
Singapore 294
Ashburn 277
Chandler 268
Seattle 242
Cambridge 201
Jacksonville 195
Dublin 164
Medford 128
Dearborn 92
Beijing 91
Santa Clara 91
Rome 62
Lawrence 53
Menlo Park 41
New York 32
San Diego 31
Zhengzhou 31
Mülheim 22
Falls Church 19
Brussels 16
Moscow 15
Munich 15
Nanjing 15
Hefei 14
Milan 14
Redwood City 14
Boardman 12
San Mateo 12
Norwalk 11
University Park 11
Shanghai 10
Dong Ket 9
Phoenix 9
London 8
Toronto 8
Verona 8
Mountain View 7
Engelhard 6
Jinan 6
Kunming 6
Florence 5
Hangzhou 5
Lappeenranta 5
Los Angeles 5
Center 4
Hong Kong 4
Kilburn 4
Redmond 4
St. George 4
Ankara 3
Brno 3
Central District 3
Chiswick 3
Codogno 3
Creede 3
Dallas 3
Detroit 3
Guangzhou 3
Helsinki 3
Hounslow 3
Islington 3
Pune 3
Seoul 3
Washington 3
Amsterdam 2
Ardabil 2
Auburn Hills 2
Augusta 2
Burbank 2
Casalecchio di Reno 2
Delhi 2
Fuzhou 2
Garbagnate Milanese 2
Hebei 2
Indiana 2
Konak 2
Kyiv 2
Mexico City 2
Monte Vista 2
Mount Washington 2
Nanchang 2
Nanning 2
New Bedfont 2
Nuremberg 2
Nürnberg 2
Paderno Dugnano 2
Padova 2
Pontecchio Polesine 2
Portici 2
Saint Petersburg 2
San Giovanni in Persiceto 2
Shenyang 2
Shenzhen 2
Suceava 2
Turin 2
Totale 11.486
Salva come PNG Salva come JPEG
Nome #
Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency 439
Chronic Granulomatous Disease Presenting with Salmonella Brain Abscesses. 438
Clinical features and follow-up in patients with 22q11.2 deletion syndrome 437
Gene therapy for immunodeficiency due to adenosine deaminase deficiency 437
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis 429
The Quality of Life of Children and Adolescents with X-Linked Agammaglobulinemia 420
Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation. 419
Etiology, clinical outcome, and laboratory features in children with neutropenia: analysis of 104 cases 416
Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID 412
In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency. 409
The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function 408
Autoimmunity and regulatory T cells in 22q11.2 deletion syndrome patients 405
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome. 398
. Early-onset monocyte-B-natural killer-dendritic cells’ deficiency successfully treated with hematopoietic stem cell transaplantation 391
Successful treatment with percutaneous transhepatic alcoholization of a liver abscess in a child with chronic granulomatous disease 382
Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease 376
Long-Term Safety and Efficacy of Gene Therapyfor Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency 374
Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) 367
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 364
Clinical features and follow-up in patients with 22q11.2 deletion syndrome 355
Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency 331
null 316
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Front Immunol. 2019 Apr 11;10:316. doi: 10.3389/fimmu.2019.00316. eCollection 2019. Erratum in: Front Immunol. 2019 May 31;10:1184. 244
Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies 244
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy 180
Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: Analysis of function and distribution in lymphoid organs 179
JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene 177
Impaired X-CGD T cell compartment is gp91phox-NADPH oxidase independent 175
The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment 163
First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia 163
ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency 161
How I treat ADA deficiency 154
Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy 142
Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID 140
Comprehensive genomic access to vector integration in clinical gene therapy. 140
Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection 139
Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. 138
Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet) 138
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 137
Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID 135
Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy 132
Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models 129
Dendritic cell functional improvement in a preclinical model of lentiviral-mediated gene therapy for Wiskott-Aldrich syndrome 126
Gene therapy for adenosine deaminase deficiency. 124
Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency 123
Gene therapy for primary immunodeficiencies: Part 1 121
Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell. 120
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 116
Retroviral integrations in gene therapy trials 115
Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency. 114
Gene therapy for primary immunodeficiencies: Part 2 114
A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis 110
New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy. 106
Ten years of gene therapy for primary immuno deficiencies 83
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999-2019) 79
Severe Toxoplasma gondii infection in a member of a NFKB2-deficient family with T and B cell dysfunction 62
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 46
SARS-CoV-2-related MIS-C: a key to the viral and genetic causes of Kawasaki disease? 43
SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity 40
Autoantibodies against type I IFNs in patients with life-threatening COVID-19 38
Natural history of Ras-associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression 34
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 31
Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait? 27
Harnessing type I IFN immunity against SARS-CoV-2 with early administration of IFN-β 27
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase 26
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 20
A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis 20
From your nose to your toes: a review of severe acute respiratory syndrome Coronavirus 2 pandemic‒associated pernio 18
Studying severe long COVID to understand post-infectious disorders beyond COVID-19 16
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 10
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 10
Totale 13.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.905
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.037 0 0 216 305 277 352 358 344 399 327 207 252
2020/20212.434 223 276 209 330 286 224 293 250 99 87 110 47
2021/2022678 22 72 29 35 43 49 32 46 84 46 37 183
2022/2023767 86 59 28 86 56 186 74 43 64 10 54 21
2023/2024292 34 27 20 14 37 64 13 20 12 0 7 44
2024/2025590 54 376 160 0 0 0 0 0 0 0 0 0
Totale 13.852